Psoriasis
Article
An Open-Label, Multicenter Study of the Efficacy and Safety of an AM/PM Treatment Regimen With Clobetasol Propionate Spray 0.05% and Calcitriol Ointment 3 μg/g in the Management of Plaque Psoriasis
Psoriasis is a chronic condition with serious quality-of-life ramifications. Dermatologists seek alternative treatments of patients with plaque...
News
Topical Combo Shows Early Promise in Moderate Psoriasis
Major Finding: In a study of 168 patients, 50% of patients with moderate psoriasis who used a combination of calcipotriene 0.005% plus...
News
DMARDs for Psoriasis May Cut Diabetes Risk
Major Finding: The hazard ratios for diabetes were 0.62 for patients taking TNF inhibitors and 0.54 for patients taking hydroxychloroquine,...
News
Biologics Don't Increase Herpes Zoster Risk
Major Finding: No cases of herpes zoster occurred in psoriasis patients on alefacept (Amevive), efalizumab (Raptiva) or adalimumab (Humira).Data...
News
308-nm Excimer Laser Effective for Treating Palmoplantar Psoriasis
Major Finding: At the end of the treatments, all patients showed 50%-100% reductions in scaling, erythema, and flattened plaquesData Source: The...
News
Rituximab Deemed Useful for Certain Lupus Subgroups
News
Bosentan May Reduce Skin Fibrosis in Scleroderma
News
Patient Subgroup Response to Belimumab Remains Unclear
News
Clobex Followed by Vectical Wallops Psoriasis
Major Finding: Eighty percent of patients were rated clear, almost clear, or mild at week 2, as were 93% at week 4, 92% at week 8, and 74% at week...
News
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk
Major Finding: The relative risk of developing a first cancer with anti-TNF therapy vs.